The Evolving Role of Multimodality Imaging in Heart Failure

2016 ◽  
pp. 183-204
Author(s):  
Alessia Gimelli ◽  
Riccardo Liga
2021 ◽  
pp. postgradmedj-2021-139933
Author(s):  
Akash Batta ◽  
Ganesh Kasinadhuni ◽  
Manphool Singhal ◽  
Pankaj Malhotra ◽  
Rajesh Vijayvergiya

2018 ◽  
Vol 71 (11) ◽  
pp. A1581
Author(s):  
Paola Scarparo ◽  
Nicolo’ Salvi ◽  
Lucia Ilaria Birtolo ◽  
Viviana Frantellizzi ◽  
Paolo Severino ◽  
...  

2020 ◽  
Vol 134 (1) ◽  
pp. 71-72
Author(s):  
Naseer Ahmed ◽  
Masooma Naseem ◽  
Javeria Farooq

Abstract Recently, we have read with great interest the article published by Ibarrola et al. (Clin. Sci. (Lond.) (2018) 132, 1471–1485), which used proteomics and immunodetection methods to show that Galectin-3 (Gal-3) down-regulated the antioxidant peroxiredoxin-4 (Prx-4) in cardiac fibroblasts. Authors concluded that ‘antioxidant activity of Prx-4 had been identified as a protein down-regulated by Gal-3. Moreover, Gal-3 induced a decrease in total antioxidant capacity which resulted in a consequent increase in peroxide levels and oxidative stress markers in cardiac fibroblasts.’ We would like to point out some results stated in the article that need further investigation and more detailed discussion to clarify certain factors involved in the protective role of Prx-4 in heart failure.


Sign in / Sign up

Export Citation Format

Share Document